Exostar, whose cloud-based solutions enable secure, cost-effective business-to-business collaboration, today announced that its Federated Identity Service (FIS) on-demand digital credential service is now fully-compliant with the SAFE-BioPharma® digital identity and signature standard. By cross-certifying with the SAFE-BioPharma Bridge Certificate Authority (SBCA), Exostar can now issue credentials that are compliant with SAFE-BioPharma and provide industry-recognized authentication and digital signature services for companies and their employees across the pharmaceutical and healthcare industries.
"We welcome Exostar as a partner in helping fulfill our vision of transitioning the biopharmaceutical and healthcare communities to paperless environments," said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association.
FIS is Exostar's hosted, managed service for the issuance and maintenance of public key infrastructure (PKI) digital certificates. FIS is a comprehensive PKI solution that enables:
- Complete lifecycle management of certificates;
- Strong authentication practices;
- Controlled access to applications at a variety of authentication levels, including basic level of assurance (for both identity and secure email purposes), medium-software level of assurance, and medium-hardware level of assurance.
Because FIS is a hosted service, Exostar handles everything, including on-boarding, training, support, and even in-person proofing when required. With FIS, companies can minimize risk and assure their resources and intellectual assets are protected over the extended enterprise.